Smith & Nephew Plc
21 April 2004
Timing of Smith & Nephew First Quarter Results
21 April 2004
Smith & Nephew plc will be announcing its results for the first quarter ending 3
April 2004 on Thursday 6 May at 12 noon BST/7am EST. This will be followed by a
conference call with financial analysts by conference call at 3.30pm BST/10.30am
EST, and can be heard live via webcast on the Smith & Nephew website at
www.smith-nephew.com
About Us
Smith & Nephew (LSE: SN, NYSE:SNN) is one of the world's leading medical devices
companies, specialising in Orthopaedics, Endoscopy and Advanced Wound
Management. Smith & Nephew ranks as the global leader in arthroscopy and
advanced wound management and is the fastest growing full-line orthopaedics
company in the world.
Smith & Nephew is dedicated to helping improve people's lives. The company
prides itself in the strength of its relationships with its surgeon and
healthcare professional customers, with whom its name is synonymous with the
highest standards of performance, innovation and trust. The company has over
7,000 employees and operates in 32 countries around the world, generating sales
of £1.2 billion.
Enquiries:
Smith & Nephew
Peter Nind Tel: +44 (0)20 7401 7646
Corporate Affairs Manager
Financial Dynamics
David Yates Tel: +44 (0)20 7831 3113
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.